Therapeutics: Integrin α9β1; integrin α4β1 (CD49D/CD29)

Hematology

INDICATION: Bone marrow transplant (BMT)

Mouse studies suggest dual inhibition of integrin α9β1 and integrin α4β1 in donors could

Read the full 181 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE